[1]
Lee, H. et al. 2019. Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance. Mediterranean Journal of Hematology and Infectious Diseases. 11, 1 (Jan. 2019), e2019007. DOI:https://doi.org/10.4084/mjhid.2019.007.